Director's Executive Group
The Director's Executive Group (DEG ) is the most senior management forum for discussion and decision on management and policy issues affecting the operations of the Institute. Members have a responsibility to be up-to-date on external policy, and on collaborative and competitive issues that have an impact on the Institute's long range planning.
The Director's Executive Group's key responsibilities relate to the provision of advice and support to the Director, co-ordinating management input to the strategic planning process, and the approval of annual budgets for presentation to the Board. The Director's Executive Group is supported by two policy and strategy focused committees, the Science Council and the Management Committee.
Membership
Chair: Garry Jennings Members: David Lloyd Mark Cooper Jaye Chin-Dusting Bronwyn Kingwell
David Kaye Jonathan Shaw Murray Esler
Science Council
The Science Council is the primary forum for scientific policy and strategy, and provides advice to DEG on issues relating to the Institute's scientific governance and planning. The Science Council consider issues such as grant and publication strategy, the purchase of scientific equipment, and the management and oversight of platform technologies.
All members of the Science Council have a responsibility to understand and contribute to the strategic evolution of the Institute's scientific research agenda, and to show a capacity for reflection and contribution beyond the confines of their own scientific interests. The Council aims to hold the Institute's scientific output to account against the Institute's clinically focussed mission statement.
The Science Council is supported by three subcommittees; the Grants Committee, the Equipment Committee, and the Early Career Scientists Committee.
Membership
| Chair: | Mark Cooper |
| Members: | Garry Jennings |
| Paul Zimmet | |
| Jaye Chin-Dusting | |
| Bronwyn Kingwell | |
| David Lloyd | |
| Alex Bobik | |
| Assam El-Osta | |
| Murray Esler | |
| Mark Febbraio | |
| Heather Gallichio | |
| Geoff Head | |
| David Kaye | |
| Karin Jandeleit-Dahm | |
| Karlheinz Peter | |
| Jonathan Shaw | |
| Simon Stewart | |
| Elizabeth Woodcock | |
| Guy Krippner | |
| Ross Lazarus | |
| Simon Stewart | |
| Markus Schlaich | |
Management Committee
The Management Committee has responsibility for the administration and management of the Institute in support of its scientific output and clinical service delivery, and provides advice to the Director's Executive Group on issues relating to the Institute's administration, including its strategic, operational and financial health. Its membership comprises members of the Institute's management with line responsibility for the internal service delivery of all support functions;
- community, corporate and government relations
- commercialisation and research contract management
- clinical and research services
- and the provision of financial reports and legal issues.
All members of the Management Committee have a responsibility to understand the operational pressures on the scientific and clinical service delivery staff of the Institute in their work, and to reflect on ways in which the Institute can continuously improve its support to them.
The Management Committee is supported by two subcommittees; the IT committee and the Occupational Health & Safety Committee.
Membership
Chair: David Lloyd Members: Garry Jennings Hilary Bolton Mark Cooper Anita Furnell Leora Harrison Guy Krippner Jacqueline Goodall Neale Cohen
